Members |
associationTargetComponent |
Xyzal (levocetirizine dihydrochloride 5 mg) film-coated tablet, 7 tablets (trade product pack) |
Unknown Cell Type 2 |
Xyzal (levocetirizine dihydrochloride 5 mg) film-coated tablet, 7 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Xyzal 5 mg film-coated tablet |
Unknown Cell Type 2 |
Xyzal 5 mg film-coated tablet, 1 |
Unknown Cell Type 2 |
Xyzal 5 mg film-coated tablet, 1, blister pack |
Unknown Cell Type 2 |
Xyzal 5 mg film-coated tablet, 10 |
Unknown Cell Type 2 |
Xyzal 5 mg film-coated tablet, 10, blister pack |
Unknown Cell Type 2 |
Xyzal 5 mg film-coated tablet, 2 |
Unknown Cell Type 2 |
Xyzal 5 mg film-coated tablet, 2, blister pack |
Unknown Cell Type 2 |
Xyzal 5 mg film-coated tablet, 28 |
Unknown Cell Type 2 |
Xyzal 5 mg film-coated tablet, 28, blister pack |
Unknown Cell Type 2 |
Xyzal 5 mg film-coated tablet, 30 |
Unknown Cell Type 2 |
Xyzal 5 mg film-coated tablet, 30, blister pack |
Unknown Cell Type 2 |
Xyzal 5 mg film-coated tablet, 7 |
Unknown Cell Type 2 |
Xyzal 5 mg film-coated tablet, 7, blister pack |
Unknown Cell Type 2 |
Yaba-Tanapox subgroup virus |
Yatapoxvirus species |
Yasmin (drospirenone 3 mg + ethinylestradiol 30 microgram) film-coated tablet |
Unknown Cell Type 2 |
Yasmin (drospirenone 3 mg + ethinylestradiol 30 microgram) film-coated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Yasmin (drospirenone 3 mg + ethinylestradiol 30 microgram) film-coated tablet [21 tablets] (&) (inert substance) film-coated tablet [7 tablets], 28 tablets (trade product pack) |
Unknown Cell Type 2 |
Yasmin (drospirenone 3 mg + ethinylestradiol 30 microgram) film-coated tablet [21 tablets] (&) (inert substance) film-coated tablet [7 tablets], 28 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Yasmin (drospirenone 3 mg + ethinylestradiol 30 microgram) film-coated tablet [21 tablets] (&) (inert substance) film-coated tablet [7 tablets], 3 x 28 tablets (trade product pack) |
Unknown Cell Type 2 |
Yasmin (drospirenone 3 mg + ethinylestradiol 30 microgram) film-coated tablet [21 tablets] (&) (inert substance) film-coated tablet [7 tablets], 3 x 28 tablets, blister packs (containered trade product pack) |
Unknown Cell Type 2 |
Yasmin (drospirenone 3 mg + ethinyloestradiol 30 microgram) film-coated tablet |
Unknown Cell Type 2 |
Yasmin (drospirenone 3 mg + ethinyloestradiol 30 microgram) film-coated tablet [21 tablets] (&) (inert substance) film-coated tablet [7 tablets], 28 tablets |
Unknown Cell Type 2 |
Yasmin (drospirenone 3 mg + ethinyloestradiol 30 microgram) film-coated tablet [21 tablets] (&) (inert substance) film-coated tablet [7 tablets], 28 tablets, blister pack |
Unknown Cell Type 2 |
Yasmin (drospirenone 3 mg + ethinyloestradiol 30 microgram) film-coated tablet [21 tablets] (&) (inert substance) film-coated tablet [7 tablets], 3 x 28 tablets |
Unknown Cell Type 2 |
Yasmin (drospirenone 3 mg + ethinyloestradiol 30 microgram) film-coated tablet [21 tablets] (&) (inert substance) film-coated tablet [7 tablets], 3 x 28 tablets, blister packs |
Unknown Cell Type 2 |
Yasmin (inert substance) film-coated tablet |
Unknown Cell Type 2 |
Yasmin (inert substance) film-coated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinylestradiol 20 microgram) uncoated tablet |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinylestradiol 20 microgram) uncoated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinylestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 2 x 28 tablets (trade product pack) |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinylestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 2 x 28 tablets, blister packs (containered trade product pack) |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinylestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 28 tablets (trade product pack) |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinylestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 28 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinylestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 3 x 28 tablets (trade product pack) |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinylestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 3 x 28 tablets, blister packs (containered trade product pack) |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinylestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 4 x 28 tablets (trade product pack) |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinylestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 4 x 28 tablets, blister packs (containered trade product pack) |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinylestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 6 x 28 tablets (trade product pack) |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinylestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 6 x 28 tablets, blister packs (containered trade product pack) |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinyloestradiol 20 microgram) uncoated tablet |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinyloestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 2 x 28 tablets |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinyloestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 2 x 28 tablets, blister packs |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinyloestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 28 tablets |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinyloestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 28 tablets, blister pack |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinyloestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 3 x 28 tablets |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinyloestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 3 x 28 tablets, blister packs |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinyloestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 4 x 28 tablets |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinyloestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 4 x 28 tablets, blister packs |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinyloestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 6 x 28 tablets |
Unknown Cell Type 2 |
Yaz (drospirenone 3 mg + ethinyloestradiol 20 microgram) uncoated tablet [24 tablets] (&) (inert substance) uncoated tablet [4 tablets], 6 x 28 tablets, blister packs |
Unknown Cell Type 2 |
Yaz (inert substance) uncoated tablet |
Unknown Cell Type 2 |
Yaz (inert substance) uncoated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Yellow atrophy of the liver |
Hepatic necrosis |
Yellow fever live attenuated vaccine |
yellow fever virus live antigen |
Yellow fever live attenuated vaccine |
yellow fever live vaccine |
Yellow fever live attenuated vaccine 1000 units injection, vial |
yellow fever live vaccine injection, vial |
Yemen Arab Republic |
Yemen |
Yersinia enterocolitica biotype 1A serotype O:8,19 |
Yersinia enterocolitica biotype 1A serotype O:19,8 |
Yersinia enterocolitica serogroup O:8,19 |
Yersinia enterocolitica serogroup O:19,8 |
Yervoy (ipilimumab 200 mg / 40 mL) concentrated injection, 1 x 40 mL vial (containered trade product pack) |
Unknown Cell Type 2 |
Yervoy (ipilimumab 200 mg / 40 mL) concentrated injection, 1 x 40 mL vial (trade product pack) |
Unknown Cell Type 2 |
Yervoy (ipilimumab 200 mg / 40 mL) concentrated injection, 40 mL vial (trade product unit of use) |
Unknown Cell Type 2 |
Yervoy (ipilimumab 50 mg / 10 mL) concentrated injection, 1 x 10 mL vial (containered trade product pack) |
Unknown Cell Type 2 |
Yervoy (ipilimumab 50 mg / 10 mL) concentrated injection, 1 x 10 mL vial (trade product pack) |
Unknown Cell Type 2 |
Yervoy (ipilimumab 50 mg / 10 mL) concentrated injection, 10 mL vial (trade product unit of use) |
Unknown Cell Type 2 |
Yervoy 200 mg/40 mL concentrated injection, 40 mL vial |
Unknown Cell Type 2 |
Yervoy 200 mg/40 mL concentrated injection, 40 mL vial |
Unknown Cell Type 2 |
Yervoy 200 mg/40 mL concentrated injection, 40 mL vial |
Unknown Cell Type 2 |
Yervoy 50 mg/10 mL concentrated injection, 10 mL vial |
Unknown Cell Type 2 |
Yervoy 50 mg/10 mL concentrated injection, 10 mL vial |
Unknown Cell Type 2 |
Yervoy 50 mg/10 mL concentrated injection, 10 mL vial |
Unknown Cell Type 2 |
Yomax (amoxicillin 250 mg) hard capsule (trade product unit of use) |
Unknown Cell Type 2 |
Yomax (amoxicillin 250 mg) hard capsule, 20 capsules (trade product pack) |
Unknown Cell Type 2 |
Yomax (amoxicillin 250 mg) hard capsule, 20 capsules, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Yomax (amoxicillin 500 mg) hard capsule (trade product unit of use) |
Unknown Cell Type 2 |
Yomax (amoxicillin 500 mg) hard capsule, 20 capsules (trade product pack) |
Unknown Cell Type 2 |
Yomax (amoxicillin 500 mg) hard capsule, 20 capsules, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Yomax 250 mg hard capsule |
Unknown Cell Type 2 |
Yomax 250 mg hard capsule, 20 |
Unknown Cell Type 2 |
Yomax 250 mg hard capsule, 20, blister pack |
Unknown Cell Type 2 |
Yomax 500 mg hard capsule |
Unknown Cell Type 2 |
Yomax 500 mg hard capsule, 20 |
Unknown Cell Type 2 |
Yomax 500 mg hard capsule, 20, blister pack |
Unknown Cell Type 2 |
Yus type |
Yus type |
Z-score |
Z-score calculation technique |
Z.S.C. (Sigma) (chlorphenesin 10 mg / 1 g + maize starch 558.5 mg / 1 g + purified talc 180.7 mg / 1 g + zinc oxide 250 mg / 1 g) dusting powder (trade product unit of use) |
Unknown Cell Type 2 |
Z.S.C. (Sigma) (chlorphenesin 10 mg / 1 g + maize starch 558.5 mg / 1 g + purified talc 180.7 mg / 1 g + zinc oxide 250 mg / 1 g) dusting powder, 100 g (trade product pack) |
Unknown Cell Type 2 |
Z.S.C. (Sigma) (chlorphenesin 10 mg / 1 g + maize starch 558.5 mg / 1 g + purified talc 180.7 mg / 1 g + zinc oxide 250 mg / 1 g) dusting powder, 100 g, bottle (containered trade product pack) |
Unknown Cell Type 2 |
Z.S.C. (Sigma) dusting powder |
Unknown Cell Type 2 |
Z.S.C. (Sigma) dusting powder, 100 g |
Unknown Cell Type 2 |
Z.S.C. (Sigma) dusting powder, 100 g, bottle |
Unknown Cell Type 2 |
Zabel (terbinafine 250 mg) uncoated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Zabel (terbinafine 250 mg) uncoated tablet, 42 tablets (trade product pack) |
Unknown Cell Type 2 |
Zabel (terbinafine 250 mg) uncoated tablet, 42 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Zabel 250 mg uncoated tablet |
Unknown Cell Type 2 |
Zabel 250 mg uncoated tablet, 42 |
Unknown Cell Type 2 |
Zabel 250 mg uncoated tablet, 42, blister pack |
Unknown Cell Type 2 |
Zactin 20 mg dispersible tablet |
Zactin 20 mg tablet |
Zactin 20 mg dispersible tablet, 28 |
Zactin 20 mg tablet, 28 |